Oncology Clinical Trials
Recruiting oncology studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat oncology. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting oncology studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting oncology trials
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
Connecting People With Cancer to Employment Support
PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer
Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer
Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department
TeamTalk: Improving Inter-professional Communication During Cancer Treatment
Improving Affordability in Cancer Care Through Economic Screening and Support (I-ACCESS)
EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors
A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods
Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
Korea Post Marketing Surveillance (PMS) Study of Talzenna®
A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
Early Intervention
Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
Information-providing Chatbot
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Maximizing Quality of Life After Cancer Through Rehabilitation
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
The High Fiber Program to Increase Fiber Intake Among Patients Undergoing Allogeneic Hematopoietic Cell Transplant
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
Strategies to Decentralize Breast Ultrasound in Rwanda
Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer
Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring
Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
NG101m Adjuvant Therapy in Glioblastoma Patients
Outside the Cage (OTC) Robotic Esophagectomy
A Study to Learn More About Tukysa Once it is Out in the Korean Market
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
Optimizing Functional Recovery After Breast Cancer Treatment
Novel mRNA-LNP-Based Intratumoral Immunotherapy in Patients With Advanced Malignant Solid Tumors
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Menin-Inhibitor Targeted Maintenance in AML
Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions
Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery
GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal Cancer
Oncology clinical trials — common questions
Are oncology clinical trials free to join?
Yes. Participating in a oncology clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a oncology clinical trial?
Each oncology study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a oncology trial near me?
Use the location controls above. We'll show recruiting oncology trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many oncology trials are recruiting right now?
We're currently tracking roughly 7430 recruiting oncology trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.